<VariationArchive RecordType="classified" VariationID="654267" VariationName="NM_000268.4(NF2):c.517-92_568del" VariationType="Deletion" Accession="VCV000654267" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-08-14" MostRecentSubmission="2019-08-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653616" VariationID="654267">
      <GeneList>
        <Gene Symbol="NF2" FullName="NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor" GeneID="4771" HGNC_ID="HGNC:7773" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29603556" stop="29698600" display_start="29603556" display_stop="29698600" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29999544" stop="30094588" display_start="29999544" display_stop="30094588" Strand="+" />
          </Location>
          <OMIM>607379</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000268.4(NF2):c.517-92_568del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29655496" stop="29655639" display_start="29655496" display_stop="29655639" variantLength="144" positionVCF="29655495" referenceAlleleVCF="TTTACTGTTTTGTAAAAATGATGCATAATTATAAAAGTGGCAAACAATACCAAATTTACTTCATGTGTAGGTTTTTTATTTTGCTCTATTTTTTGGTAGGTAATAAATCTGTATCAGATGACTCCGGAAATGTGGGAGGAGAGAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="30051485" stop="30051628" display_start="30051485" display_stop="30051628" variantLength="144" positionVCF="30051484" referenceAlleleVCF="TTTACTGTTTTGTAAAAATGATGCATAATTATAAAAGTGGCAAACAATACCAAATTTACTTCATGTGTAGGTTTTTTATTTTGCTCTATTTTTTGGTAGGTAATAAATCTGTATCAGATGACTCCGGAAATGTGGGAGGAGAGAA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t1" sequenceAccession="LRG_511t1">
            <Expression>LRG_511t1:c.517-98_562del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t2" sequenceAccession="LRG_511t2">
            <Expression>LRG_511t2:c.517-92_568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_511" sequenceAccession="LRG_511">
            <Expression>LRG_511:g.56947_57090del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.30051491_30051634del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.30051491_30051634del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.29655502_29655645del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.29655502_29655645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009057.1" sequenceAccession="NG_009057" sequenceVersion="1" change="g.56947_57090del">
            <Expression>NG_009057.1:g.56947_57090del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016418.5" sequenceAccession="NM_016418" sequenceVersion="5" change="c.517-92_568del">
            <Expression>NM_016418.5:c.517-92_568del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181832.3" sequenceAccession="NM_181832" sequenceVersion="3" change="c.517-92_568del">
            <Expression>NM_181832.3:c.517-92_568del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000268.4" sequenceAccession="NM_000268" sequenceVersion="4" change="c.517-92_568del" MANESelect="true">
            <Expression>NM_000268.4:c.517-92_568del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181833.3" sequenceAccession="NM_181833" sequenceVersion="3" change="c.447+13217_447+13360del">
            <Expression>NM_181833.3:c.447+13217_447+13360del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181829.3" sequenceAccession="NM_181829" sequenceVersion="3" change="c.394-92_445del">
            <Expression>NM_181829.3:c.394-92_445del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181828.3" sequenceAccession="NM_181828" sequenceVersion="3" change="c.391-92_442del">
            <Expression>NM_181828.3:c.391-92_442del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181830.3" sequenceAccession="NM_181830" sequenceVersion="3" change="c.268-92_319del">
            <Expression>NM_181830.3:c.268-92_319del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181831.3" sequenceAccession="NM_181831" sequenceVersion="3" change="c.268-92_319del">
            <Expression>NM_181831.3:c.268-92_319del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181825.3" sequenceAccession="NM_181825" sequenceVersion="3" change="c.517-92_568del">
            <Expression>NM_181825.3:c.517-92_568del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1601613230" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000268.4(NF2):c.517-92_568del AND Neurofibromatosis, type 2" Accession="RCV000810194" Version="1">
        <ClassifiedConditionList TraitSetID="840">
          <ClassifiedCondition DB="MedGen" ID="C0027832">Neurofibromatosis, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-11-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2019-08-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3089" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NF 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis central type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic schwannomas bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bilateral acoustic neurofibromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acoustic neurinoma bilateral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCHWANNOMATOSIS, VESTIBULAR</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurofibromatosis, type 2</ElementValue>
                <XRef ID="Neurofibromatosis+type+2/5175" DB="Genetic Alliance" />
                <XRef ID="92503002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BANF</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SWNV</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ACN</ElementValue>
                <XRef Type="MIM" ID="101000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7193" />
                <XRef ID="7193" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neurofibromatosis 2 (NF2) is characterized by bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction. The average age of onset is 18 to 24 years. Almost all affected individuals develop bilateral vestibular schwannomas by age 30 years. Affected individuals may also develop schwannomas of other cranial and peripheral nerves, meningiomas, ependymomas, and, very rarely, astrocytomas. Because NF2 is considered an adult-onset disease, it may be underrecognized in children, in whom skin tumors and ocular findings (retinal hamartoma, thickened optic nerves, cortical wedge cataracts, third cranial nerve palsy) may be the first manifestations. Mononeuropathy that occurs in childhood is an increasingly recognized finding; it frequently presents as a persistent facial palsy or hand/foot drop.</Attribute>
                <XRef ID="NBK1201" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000335543" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335548" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551653" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521547" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552306" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510681" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514608" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552305" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511190" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528652" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551659" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552308" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576339" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301380</ID>
                <ID Source="BookShelf">NBK1201</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2020">
                <ID Source="PubMed">32602153</ID>
              </Citation>
              <XRef ID="637" DB="Orphanet" />
              <XRef ID="C0027832" DB="MedGen" />
              <XRef ID="MONDO:0007039" DB="MONDO" />
              <XRef Type="MIM" ID="101000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1844485" SubmissionDate="2019-03-28" DateLastUpdated="2019-08-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5104364|MedGen:C0027832" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000950387" DateUpdated="2019-08-14" DateCreated="2019-08-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing part of exon 6 (c.517-92_568del) of the NF2 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has been observed to be de novo in an individual with clinical features of neurofibromatosis, type 2 (Invitae). Loss-of-function variants in NF2 are known to be pathogenic (PMID: 9643284, 16983642). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NF2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000268.3:c.517-98_562del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Neurofibromatosis, type 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027832" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1844485" TraitType="Disease" MappingType="Name" MappingValue="Neurofibromatosis, type 2" MappingRef="Preferred">
        <MedGen CUI="C0027832" Name="Neurofibromatosis, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

